Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts

Kristel Kemper(The Netherlands Cancer Institute), Daniel S. Peeper(The Netherlands Cancer Institute)
EMBO Molecular Medicine
June 23, 2015
10.15252/emmm.201404914
Cited by 143

Related Papers

BRAFE600-associated senescence-like cell cycle arrest of human naevi
|Nature|2005|2.1k
The essence of senescence: Figure 1.
|Genes & Development|2010|2k
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
|Nature Communications|2014|633
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
|Nature|2017|161
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
|Nature Communications|2020|117